Related Experiment Video

Updated: Apr 25, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

9.3K

NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity

Jordan T Gladman1, Ramesh S Yadava1, Mahua Mandal1

  • 1Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.

Human Molecular Genetics
|August 30, 2014
PubMed

Insights

Increased NKX2-5 expression contributes to muscle damage in myotonic dystrophy type 1 (DM1). Reducing NKX2-5 levels can improve muscle pathology, even with ongoing toxic RNA presence, offering potential therapeutic insights.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pathology

Background:

  • RNA toxicity is linked to various disorders, notably myotonic dystrophy type 1 (DM1).
  • Previous research indicated elevated NKX2-5 expression in DM1-associated RNA toxicity.

Purpose of the Study:

  • To investigate the connection between NKX2-5 expression and muscle pathology in RNA toxicity.
  • To explore NKX2-5's role in myogenic differentiation and muscle regeneration.

Main Methods:

  • Analysis of skeletal muscle from DM1 patients and mouse models.
  • Over-expression and knockdown studies in C2C12 myoblasts.
  • Assessment of muscle regeneration in NKX2-5 over-expression mouse models.

Main Results:

  • NKX2-5 expression correlated with histopathological severity in DM1 skeletal muscle.
  • NKX2-5 over-expression or mutant DMPK 3'UTR impaired myogenic differentiation.
  • NKX2-5 knockdown rescued differentiation defects, and NKX2-5 levels modulated disease phenotypes.

Conclusions:

  • NKX2-5 plays a significant role in RNA toxicity-induced muscle pathology.
  • Modulating NKX2-5 levels offers a potential therapeutic strategy for DM1 and related disorders.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

12.4K
Functional Characterization of Endogenously Expressed Human RYR1 Variants07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.3K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.4K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.6K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.0K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
6.6K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
9.3K